Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Anosheh, Afghahi"'
Autor:
Anthony D. Elias, Nicole S. Spoelstra, Alyse W. Staley, Sharon Sams, Lyndsey S. Crump, Gregory A. Vidal, Virginia F. Borges, Peter Kabos, Jennifer R. Diamond, Elena Shagisultanova, Anosheh Afghahi, Jose Mayordomo, Tessa McSpadden, Gloria Crawford, Angelo D’Alessandro, Kathryn L. Zolman, Adrie van Bokhoven, Yonghua Zhuang, Rosa I. Gallagher, Julia D. Wulfkuhle, Emanuel F. Petricoin III, Dexiang Gao, Jennifer K. Richer
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-10 (2023)
Abstract This clinical trial combined fulvestrant with the anti-androgen enzalutamide in women with metastatic ER+/HER2− breast cancer (BC). Eligible patients were women with ECOG 0–2, ER+/HER2− measurable or evaluable metastatic BC. Prior fulv
Externí odkaz:
https://doaj.org/article/ad0c82b5d82a4e81a6170a0a923d1435
Autor:
Allison H. West, Hayley Knollman, James Dugan, Donald Hedeker, Elisabeth A. Handorf, Sarah M. Nielsen, Lisa C. Bealin, Lindsay G. Goldblatt, Heather Willems, Mary B. Daly, Anosheh Afghahi, Olufunmilayo I. Olopade, Peter J. Hulick, Elena Shagisultanova, Dezheng Huo, Elias Obeid, Jane E. Churpek
Publikováno v:
Cancer Medicine, Vol 8, Iss 12, Pp 5609-5618 (2019)
Abstract Women who inherit a BRCA1 or BRCA2 mutation have an increased risk of breast cancer. Preliminary evidence suggests they may also have defects in bone marrow function. To test this hypothesis, we conducted a multicenter, retrospective, matche
Externí odkaz:
https://doaj.org/article/d695927560f54771808c59d4bbf454a7
Autor:
Amrita Basu, Saumya Umashankar, Kaylee Blevins, Anna Northrop, Anika Christofferson, Ebunoluwa Olunuga, Jaeyoon Cha, Ananya Mittal, Julissa Molina-Vega, Laura Sit, Thelma Brown, Bev Parker, Diane Heditsian, Susie Brain, Carol Simmons, Alessandra Taboada, Tina J. Hieken, Kathryn Ruddy, Carolina Salvador, Candace Mainor, Anosheh Afghahi, Sarah Tevis, Anne Blaes, Irene M. Kang, Jane Perlmutter, Hope Rugo, Sai Kanaparthi, Garry Peterson, Lisa T. Weiss, Adam Asare, Laura J. Esserman, Michelle Melisko, Dawn Hershman
Publikováno v:
Cancer Research. 83:P5-07
Background. Patient-reported outcomes (PROs) are increasingly recognized as a valuable component to understand treatment tolerability and toxicity among patients on clinical trials. We have implemented a system for monitoring patient reported outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83ceaa8ddecc389b4ebe1e9ddb64f749
https://doi.org/10.1158/1538-7445.sabcs22-p5-07-03
https://doi.org/10.1158/1538-7445.sabcs22-p5-07-03
Autor:
Victoria Huynh, Sudheer Vemuru, Karen Hampanda, Jessica Pettigrew, Marcella Fasano, Helen L. Coons, Kristin E. Rojas, Anosheh Afghahi, Gretchen Ahrendt, Simon Kim, Dan D. Matlock, Sarah E. Tevis
Publikováno v:
Annals of Surgical Oncology. 29:6238-6251
Using explanatory mixed methods, we characterize the education that patients with breast cancer received about potential sexual health effects of treatment and explore preferences in format, content, and timing of education.Adult patients with stage
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09ace5978d57abdcfc97cbc98d4e47d1
https://doi.org/10.1245/s10434-022-12126-7
https://doi.org/10.1245/s10434-022-12126-7
Autor:
Sudheer Vemuru, Jin Huang, Kathryn Colborn, YooJin Yoon, Victoria Huynh, Laura Leonard, Gretchen Ahrendt, Nicole Christian, Anosheh Afghahi, Lauren McLemore, Sharon Sams, Sarah Tevis
Publikováno v:
Breast Cancer Research and Treatment.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6051881b762fb3e5c2d69c45e7b0fca5
https://doi.org/10.1007/s10549-023-06978-0
https://doi.org/10.1007/s10549-023-06978-0
Autor:
Allison W. Kurian, George W. Sledge, James M. Ford, Scarlett L. Gomez, Kathleen Horst, Robert B. West, Christina N. Curtis, Sunil S. Badve, Melinda L. Telli, Joseph Rigdon, Caroline A. Thompson, Tina Seto, Maya B. Mathur, Emma Pierson, Manisha Desai, Summer S. Han, Natasha Purington, Anosheh Afghahi
Supplemental Figure 1. Patient inclusion and exclusion criteria. TNBC: triple negative breast cancer; ALC: absolute lymphocyte count; nSES: neighborhood socioeconomic status. Supplemental Figure 2a and 2b. Association between minimum lymphocyte count
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21e229c6b31b22fe96461112c719ca50
https://doi.org/10.1158/1078-0432.22464414
https://doi.org/10.1158/1078-0432.22464414
Autor:
Melinda L. Telli, James M. Ford, Anne-Renee Hartman, Elizabeth Schackmann, Pei-Jen Chang, Robert W. Carlson, Allison W. Kurian, Kristin C. Jensen, Shaveta Vinayak, Kirsten M. Timms, Anosheh Afghahi
Details of the allele frequencies in the tumor specimens of patient 15 who was found to have a somatic reversion mutation of BRCA1 in the residual tumor tissue
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5662be968ee04265300b3bc138272854
https://doi.org/10.1158/1078-0432.22463073.v1
https://doi.org/10.1158/1078-0432.22463073.v1
Autor:
Allison W. Kurian, George W. Sledge, James M. Ford, Scarlett L. Gomez, Kathleen Horst, Robert B. West, Christina N. Curtis, Sunil S. Badve, Melinda L. Telli, Joseph Rigdon, Caroline A. Thompson, Tina Seto, Maya B. Mathur, Emma Pierson, Manisha Desai, Summer S. Han, Natasha Purington, Anosheh Afghahi
Purpose: Tumor-infiltrating lymphocytes (TIL) in pretreatment biopsies are associated with improved survival in triple-negative breast cancer (TNBC). We investigated whether higher peripheral lymphocyte counts are associated with lower breast cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08468c8f61ba3b2598416fd5b077d5cb
https://doi.org/10.1158/1078-0432.c.6525711.v1
https://doi.org/10.1158/1078-0432.c.6525711.v1
Autor:
Edward E. Graves, Amato J. Giaccia, Kathleen C. Horst, Allison W. Kurian, Melissa J. Jenkins, Anosheh Afghahi, Stavros Melemenidis, Yasaman Ahrari, Meghana A. Golla, Rie von Eyben, Luis A. Soto, Laura L. Bronsart, Marta Vilalta, Todd A. Aguilera, Marjan Rafat
Although radiotherapy (RT) decreases the incidence of locoregional recurrence in breast cancer, patients with triple-negative breast cancer (TNBC) have increased risk of local recurrence following breast-conserving therapy. The relationship between R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0da5028904ca185935f29ca4d546eb8
https://doi.org/10.1158/0008-5472.c.6510065.v1
https://doi.org/10.1158/0008-5472.c.6510065.v1
Autor:
Edward E. Graves, Amato J. Giaccia, Kathleen C. Horst, Allison W. Kurian, Melissa J. Jenkins, Anosheh Afghahi, Stavros Melemenidis, Yasaman Ahrari, Meghana A. Golla, Rie von Eyben, Luis A. Soto, Laura L. Bronsart, Marta Vilalta, Todd A. Aguilera, Marjan Rafat
Table S1 summarizes the patient radiation and chemotherapy conditions. Figure S1 shows that viable tumor cells are recruited to the MFP following RT. Figure S2 shows that tumor cell recruitment is dose dependent. Figure S3 shows tumor growth curves a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::917986150f991ad817dea7058f87a903
https://doi.org/10.1158/0008-5472.22418213.v1
https://doi.org/10.1158/0008-5472.22418213.v1